Lisa Altieri1, Megan Eguchi2, David H Peng3, Myles Cockburn4. 1. Department of Dermatology, Keck School of Medicine of the University of Southern California, Los Angeles, California. Electronic address: lisa.altieri@med.usc.edu. 2. University of Colorado Cancer Center, Denver, Colorado. 3. Department of Dermatology, Keck School of Medicine of the University of Southern California, Los Angeles, California. 4. Department of Dermatology, Keck School of Medicine of the University of Southern California, Los Angeles, California; University of Colorado Cancer Center, Denver, Colorado; Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Abstract
BACKGROUND: Mucosal melanomas are rare and aggressive neoplasms, with little published population-based data on predictors of survival. OBJECTIVE: We sought to assess the influences of race/ethnicity, sex, tumor stage, tumor thickness, and anatomic site on mucosal melanoma survival estimates. METHODS: We analyzed 132,751 cases of melanoma, including 1824 mucosal melanomas, diagnosed between 1994 and 2015 and reported to the California Cancer Registry. Kaplan-Meier survival analysis and Cox proportional hazards regression assessed the prognostic variables. RESULTS: The 5-year relative survival for mucosal melanomas (27.64% [95% confidence interval {CI} 25.42-29.91) was significantly lower than for cutaneous melanomas (76.28% [95% CI 76.03-76.53]). Stage independently influenced survival, and thickness did not predict survival for neoplasms of known depth. Less common anatomic sites conferred worse prognoses (hazard ratio 1.93 [95% CI 1.41-2.64]). LIMITATIONS: The lack of a standardized staging system may have resulted in misclassification of stage for some neoplasms. The influence of genetics is unknown because our database did not contain genetic characteristics. CONCLUSIONS: Stage and anatomic site, but not thickness (ie, Breslow depth), race, or ethnicity, determine the prognosis of mucosal melanomas. Considering the poor prognosis for all stages of mucosal melanoma, dermatologists should incorporate examination of the oropharynx and genitalia in the full body skin examination.
BACKGROUND: Mucosal melanomas are rare and aggressive neoplasms, with little published population-based data on predictors of survival. OBJECTIVE: We sought to assess the influences of race/ethnicity, sex, tumor stage, tumor thickness, and anatomic site on mucosal melanoma survival estimates. METHODS: We analyzed 132,751 cases of melanoma, including 1824 mucosal melanomas, diagnosed between 1994 and 2015 and reported to the California Cancer Registry. Kaplan-Meier survival analysis and Cox proportional hazards regression assessed the prognostic variables. RESULTS: The 5-year relative survival for mucosal melanomas (27.64% [95% confidence interval {CI} 25.42-29.91) was significantly lower than for cutaneous melanomas (76.28% [95% CI 76.03-76.53]). Stage independently influenced survival, and thickness did not predict survival for neoplasms of known depth. Less common anatomic sites conferred worse prognoses (hazard ratio 1.93 [95% CI 1.41-2.64]). LIMITATIONS: The lack of a standardized staging system may have resulted in misclassification of stage for some neoplasms. The influence of genetics is unknown because our database did not contain genetic characteristics. CONCLUSIONS: Stage and anatomic site, but not thickness (ie, Breslow depth), race, or ethnicity, determine the prognosis of mucosal melanomas. Considering the poor prognosis for all stages of mucosal melanoma, dermatologists should incorporate examination of the oropharynx and genitalia in the full body skin examination.
Authors: Els R Koomen; Esther de Vries; Leon C van Kempen; Alexander C J van Akkooi; Henk Jan Guchelaar; Marieke W J Louwman; Tamar Nijsten; Jan-Willem W Coebergh Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Ahmedin Jemal; Mona Saraiya; Pragna Patel; Sai S Cherala; Jill Barnholtz-Sloan; Julian Kim; Charles L Wiggins; Phyllis A Wingo Journal: J Am Acad Dermatol Date: 2011-11 Impact factor: 11.527
Authors: Colleen C McLaughlin; Xiao-Cheng Wu; Ahmedin Jemal; Howard J Martin; Lisa M Roche; Vivien W Chen Journal: Cancer Date: 2005-03-01 Impact factor: 6.860
Authors: S Mallone; E De Vries; M Guzzo; E Midena; J Verne; J W Coebergh; R Marcos-Gragera; E Ardanaz; R Martinez; M D Chirlaque; C Navarro; G Virgili Journal: Eur J Cancer Date: 2011-11-25 Impact factor: 9.162
Authors: Joselin D Tacastacas; Julie Bray; Yoon K Cohen; Joshua Arbesman; Julian Kim; Henry B Koon; Kord Honda; Kevin D Cooper; Meg R Gerstenblith Journal: J Am Acad Dermatol Date: 2014-05-06 Impact factor: 11.527
Authors: Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton Journal: Cancers (Basel) Date: 2022-06-08 Impact factor: 6.575